Twist Bioscience Corporation (TWST)
NASDAQ: TWST · IEX Real-Time Price · USD
58.08
+0.57 (0.99%)
At close: Jul 26, 2024, 4:00 PM
60.00
+1.92 (3.31%)
After-hours: Jul 26, 2024, 7:07 PM EDT
Twist Bioscience Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Year Ending | TTM | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | 277.49 | 245.11 | 203.57 | 132.33 | 90.1 | 54.39 | Upgrade
|
| Revenue Growth (YoY) | 21.79% | 20.41% | 53.83% | 46.87% | 65.67% | 113.89% | Upgrade
|
| Cost of Revenue | 171.22 | 155.38 | 119.33 | 80.62 | 61.41 | 47.43 | Upgrade
|
| Gross Profit | 106.26 | 89.73 | 84.24 | 51.71 | 28.69 | 6.96 | Upgrade
|
| Selling, General & Admin | 201.91 | 189.74 | 212.95 | 135.9 | 103.27 | 80.13 | Upgrade
|
| Research & Development | 95.52 | 106.89 | 120.31 | 69.07 | 43.01 | 35.68 | Upgrade
|
| Other Operating Expenses | 3.47 | 3.47 | - | - | - | - | Upgrade
|
| Operating Expenses | 300.9 | 300.1 | 333.26 | 204.97 | 146.27 | 115.81 | Upgrade
|
| Operating Income | -194.64 | -210.37 | -249.02 | -153.26 | -117.58 | -108.85 | Upgrade
|
| Interest Expense | -0 | -0.01 | -0.08 | -0.37 | -0.79 | -1.29 | Upgrade
|
| Interest & Investment Income | 15.92 | 14.37 | 3.06 | 0.44 | 1.5 | 3.03 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.23 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -178.49 | -196.01 | -246.04 | -153.19 | -116.87 | -107.11 | Upgrade
|
| Merger & Restructuring Charges | -12.7 | -12.7 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 4.61 | - | - | -0.19 | Upgrade
|
| Legal Settlements | - | - | - | - | -22.5 | - | Upgrade
|
| Other Unusual Items | -0.09 | 5.25 | 13.16 | -0.84 | -0.18 | -0.08 | Upgrade
|
| Pretax Income | -191.27 | -203.47 | -228.27 | -154.03 | -139.55 | -107.38 | Upgrade
|
| Income Tax Expense | 0.87 | 1.15 | -10.41 | -1.93 | 0.38 | 0.29 | Upgrade
|
| Net Income | -192.14 | -204.62 | -217.86 | -152.1 | -139.93 | -107.67 | Upgrade
|
| Net Income to Common | -192.14 | -204.62 | -217.86 | -152.1 | -139.93 | -107.67 | Upgrade
|
| Shares Outstanding (Basic) | 57 | 57 | 54 | 48 | 39 | 27 | Upgrade
|
| Shares Outstanding (Diluted) | 57 | 57 | 54 | 48 | 39 | 27 | Upgrade
|
| Shares Change (YoY) | 1.86% | 5.57% | 11.68% | 23.12% | 42.71% | 883.24% | Upgrade
|
| EPS (Basic) | -3.35 | -3.60 | -4.04 | -3.15 | -3.57 | -3.92 | Upgrade
|
| EPS (Diluted) | -3.36 | -3.60 | -4.04 | -3.15 | -3.57 | -3.92 | Upgrade
|
| Free Cash Flow | -95.52 | -170.25 | -226.24 | -139.31 | -152.12 | -102.69 | Upgrade
|
| Free Cash Flow Per Share | -1.66 | -2.99 | -4.20 | -2.89 | -3.88 | -3.74 | Upgrade
|
| Gross Margin | 38.29% | 36.61% | 41.38% | 39.08% | 31.85% | 12.80% | Upgrade
|
| Operating Margin | -70.14% | -85.83% | -122.33% | -115.81% | -130.50% | -200.15% | Upgrade
|
| Profit Margin | -69.24% | -83.48% | -107.02% | -114.94% | -155.31% | -197.98% | Upgrade
|
| Free Cash Flow Margin | -34.42% | -69.46% | -111.14% | -105.27% | -168.84% | -188.83% | Upgrade
|
| EBITDA | -161.18 | -181.06 | -232.51 | -143.51 | -110.9 | -102.94 | Upgrade
|
| EBITDA Margin | -58.08% | -73.87% | -114.22% | -108.45% | -123.09% | -189.28% | Upgrade
|
| D&A For EBITDA | 33.47 | 29.31 | 16.51 | 9.75 | 6.68 | 5.91 | Upgrade
|
| EBIT | -194.64 | -210.37 | -249.02 | -153.26 | -117.58 | -108.85 | Upgrade
|
| EBIT Margin | -70.14% | -85.83% | -122.33% | -115.81% | -130.50% | -200.15% | Upgrade
|
| Advertising Expenses | - | 2.9 | 2.4 | 2.5 | 1.2 | 1.3 | Upgrade
|
Source: S&P Capital IQ. Standard template.